ClinicalTrials.govpublic full text
Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria
acute intermittent porphyria, porphyria, gene therapy, aav, liver gene transfer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915564
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.